LDTs Rule Update: More Support for Legal Challenges Against FDA
Key clinical laboratory organizations file amicus brief, reiterating that the FDA is overstepping its authority, and its new rule would cause “irreparable patient harm”
The latest regulatory, legal, compliance, and technology news for labs and pathology practices.
Key clinical laboratory organizations file amicus brief, reiterating that the FDA is overstepping its authority, and its new rule would cause “irreparable patient harm”
Recently released CDC data show that the largest drops occurred among groups who are most affected by HIV.
Hosted by AACC president Dr. Stephen R. Master, the talk will cover the ethics of lab testing and the role of clinical lab professionals.
Now that the Supreme Court has revoked Roe v. Wade, HHS must rework policies, programs, and procedures related to reproductive rights.
Legislation introduced last week would require the use of a more reliable representative sample to determine lab test reimbursement rates.
Two PCR assays and a PCR point-of-care solution from three different companies aim to help with diagnosing cases, tracking new variants.
A post-surgery liquid biopsy test capable of detecting ctDNA could eliminate the need for chemotherapy for some stage II cancer patients.
In this Labs in Court Weekly roundup, Molina allegedly submitted claims while not properly supervising and licensing mental health staff.
Mayo Clinic and Sheba Medical Center sign an agreement aiming to develop and release health technologies more quickly.
Research team’s prototype test is easier to use than current methods and can detect cancer markers within 4.5 hours.
A recently released preprint study shows that expanded telehealth coverage did not lead to an increase in volume for outpatient E&M services.